ALFA FinderNSE filing, NSE: QUESTLAB. Summary written from the filing by ALFA Finder's alert engine.
Quest Laboratories Ltd: key numbers
- Share price
- ₹92.90
- Market cap
- ₹152.2 Cr
- Revenue (annual)
- ₹111.8 Cr
- Net profit (annual)
- ₹15.02 Cr
- P/E (TTM)
- 10.1×Sector 43.8×
- Promoter holding
- 66.78%+0.00% QoQ
- FII holding
- 0.66%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Quest Laboratories Ltd
All →Quest Laboratories Other Announcement
Quest Laboratories reported no deviation in IPO fund utilisation for the half year ended September 2026. Its statement was reviewed by the Audit Committee.
Quest Laboratories H1 FY27 Results: Net Profit ₹9 Cr, Up 11.1% YoY
Quest Laboratories approved unaudited standalone half-year results for the period ended September 30, 2026, with a full results statement attached. Revenue, profit and balance sheet figures are disclosed in the enclosed statements.
- Key figure
- Net profit ₹9 Cr · +11.1% YoY
Quest Laboratories Annual General Meeting
Quest Laboratories Limited held its 28th Annual General Meeting on September 30, 2026. The company discussed and placed standard business resolutions for shareholder consideration and approval.
Quest Laboratories Partnership
Quest Laboratories Limited entered a strategic advisory collaboration with Niraga Capitals Private Limited to support its growth, corporate development, and strategic initiatives.
Quest Laboratories Business Update
Quest Laboratories updated its third-quarter business position, reporting export orders of ₹10.71 Crore and domestic sales of ₹16.90 Crore, with a total order book of ₹39.73 Crore.
- Order book
- ₹39.73 Cr
Quest Laboratories Capacity Expansion
Quest Laboratories Limited completed its Phase-I manufacturing expansion, with a new 12,000 sq. ft. facility becoming operational in September 2026.
- building expansion area
- 12000.0 sq. ft.
Other board meeting date announcements
All →Radhagobind Commercial Board Meeting Date
Radhagobind's Resolution Professional meets November 13, 2026 to consider unaudited half-year results. Trading window closes until 48 hours after results.
Millworks Technologies Board Meeting Date
Millworks Technologies adjourned its November 12, 2026 board meeting. The meeting will reconvene on November 13 to consider half-year unaudited results.
Taylormade Renewables Board Meeting Date
Taylormade Renewables schedules a 14 November 2026 board meeting for September-quarter unaudited results. Trading window stays closed until 48 hours after declaration.
CHD Chemicals Board Meeting Date
CHD Chemicals will hold a board meeting on 17 November 2026 to consider a rights issue of equity shares. No amount or terms disclosed yet.
Alkosign Board Meeting Date
Alkosign postponed its board meeting from November 13 to November 14, 2026, to consider half-year unaudited results. The trading window stays closed until 48 hours after the results are declared.
Gabriel Pet Straps Board Meeting Date
Gabriel Pet Straps intimated a board meeting on 14 November 2026 to approve standalone and consolidated audited results for the half year and year ended 30 September 2026. The filing is a future meeting notice with no decision taken yet.